Search alternatives:
significant level » significance level (Expand Search), significance levels (Expand Search), significant gender (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), teer decrease (Expand Search)
significant level » significance level (Expand Search), significance levels (Expand Search), significant gender (Expand Search)
higher decrease » higher degree (Expand Search), higher degrees (Expand Search), highest increase (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), teer decrease (Expand Search)
-
5501
Antibodies used for western blotting.
Published 2025“…Interestingly, Mirin, a MRN complex inhibitor which can inhibit the exonuclease activity of MRE11 and MRN-dependent activation of ATM, but not ATM kinase inhibitor KU55933, could decrease cccDNA level. Likewise, the MRE11 endonuclease activity inhibitor PFM01 treatment decreased cccDNA. …”
-
5502
Target sequences of siRNAs.
Published 2025“…Interestingly, Mirin, a MRN complex inhibitor which can inhibit the exonuclease activity of MRE11 and MRN-dependent activation of ATM, but not ATM kinase inhibitor KU55933, could decrease cccDNA level. Likewise, the MRE11 endonuclease activity inhibitor PFM01 treatment decreased cccDNA. …”
-
5503
Plasmids information.
Published 2025“…Interestingly, Mirin, a MRN complex inhibitor which can inhibit the exonuclease activity of MRE11 and MRN-dependent activation of ATM, but not ATM kinase inhibitor KU55933, could decrease cccDNA level. Likewise, the MRE11 endonuclease activity inhibitor PFM01 treatment decreased cccDNA. …”
-
5504
Raw data.
Published 2025“…Interestingly, Mirin, a MRN complex inhibitor which can inhibit the exonuclease activity of MRE11 and MRN-dependent activation of ATM, but not ATM kinase inhibitor KU55933, could decrease cccDNA level. Likewise, the MRE11 endonuclease activity inhibitor PFM01 treatment decreased cccDNA. …”
-
5505
LULC proportion from 2040 to 2060.
Published 2025“…The study highlighted significant land-use changes, with increased agriculture and built-up areas at the expense of forests and pasturelands. …”
-
5506
Global sensitive flow parameters [84].
Published 2025“…The study highlighted significant land-use changes, with increased agriculture and built-up areas at the expense of forests and pasturelands. …”
-
5507
Excel data extraction.
Published 2025“…The overall prevalence of cervical cancer screening practice in Africa was 20.94% (95% CI: 15.84%–26.04%). Women’s level of knowledge (AOR: 3.22, 95% CI: 1.64–6.33), positive attitude toward CCS (AOR: 2.48, 95% CI: 2.18–2.81), perceived vulnerability to cervical cancer (AOR = 3.57, 95% CI: 2.75, 4.63), and history of STIs (AOR = 4.89, 95% CI: 3.14, 7.62) were significantly associated with cervical cancer screening practice. …”
-
5508
Tracheostomy data.
Published 2025“…The percentage of extubation trials was found to be higher in the LT cohort (43.1%) than in the ET cohort (9.3%), resulting in prolonged ICU LOS. …”
-
5509
Flow diagram of patient selection.
Published 2025“…The percentage of extubation trials was found to be higher in the LT cohort (43.1%) than in the ET cohort (9.3%), resulting in prolonged ICU LOS. …”
-
5510
Bacterial strains used in this study.
Published 2025“…Liquid chromatography-tandem mass spectrometry analysis revealed that <i><i>P. copri</i></i> cultured in TJ medium accumulated L-(-)-3-phenyllactic acid (L-(-)-3-PLA), a compound known for its antibacterial properties through oxidative stress and its protective effects on the intestinal barrier. In contrast, the levels of known antioxidants such as 2,3,4,9-tetrahydro-1H-β-carboline-3-carboxylic acid and Cyclo(phenylalanyl-prolyl) were decreased. …”
-
5511
-
5512
Post-meal glycemic curve of T2DM patients without or with raw cinnamon.
Published 2024“…The levels of post-meal Δ blood glucose along the curve were significantly decreased by raw cinnamon ingested in the form of powder (p ≤ 0.013) and in the form of capsule (p ≤ 0.020), independently of the dose (p > 0.05), and the decreases caused by the form of powder were significantly stronger than by the form of capsule (p ≤ 0.003).…”
-
5513
Effects of βHB treatment on edema and NDS 3 days after ICH.
Published 2024“…<p>A) In experiment 2, body weight was decreased on day 1 after ICH (p<0.0001), but not different between treatment groups at all times assessed (all p≥0.2118). …”
-
5514
The basic flowchart of analysis in this study.
Published 2025“…Finally, we discovered that the levels of <i>PDK1</i> expression in AD patients were remarkably upregulated, while <i>FDX1</i> and <i>GLS</i> were significantly decreased using qPCR.…”
-
5515
The enriched GO terms of the 19 DECAGs.
Published 2025“…Finally, we discovered that the levels of <i>PDK1</i> expression in AD patients were remarkably upregulated, while <i>FDX1</i> and <i>GLS</i> were significantly decreased using qPCR.…”
-
5516
Primers of the tested genes.
Published 2025“…Finally, we discovered that the levels of <i>PDK1</i> expression in AD patients were remarkably upregulated, while <i>FDX1</i> and <i>GLS</i> were significantly decreased using qPCR.…”
-
5517
Summary of patient demographic characteristics.
Published 2025“…Finally, we discovered that the levels of <i>PDK1</i> expression in AD patients were remarkably upregulated, while <i>FDX1</i> and <i>GLS</i> were significantly decreased using qPCR.…”
-
5518
Flow chart of sequencing data comparison.
Published 2025“…In addition, interference with <i>COL1A1</i> significantly inhibited the expression of <i>PLTP</i>, <i>ABHD6</i>, <i>LPIN1</i>, and <i>PTGS2</i> and decreased the levels of triglycerides and cholesterol at 4 and 8 days. …”
-
5519
Gene ontology (GO) term for DEGs.
Published 2025“…In addition, interference with <i>COL1A1</i> significantly inhibited the expression of <i>PLTP</i>, <i>ABHD6</i>, <i>LPIN1</i>, and <i>PTGS2</i> and decreased the levels of triglycerides and cholesterol at 4 and 8 days. …”
-
5520
Qualitative changes in the implant subgroup.
Published 2025“…In the study group, the IOP was statistically significantly lower by 29% at the end of the follow-up compared to the preoperative measurements (<i><i>p</i></i> = 0.009). …”